Martin Shkreli, the former drug company executive who drew public outcry when he raised the price of a life-saving drug by 5,000 percent, will be tried for securities fraud separately from a lawyer.. Raw Story Also reported by •Reuters
On a recent evening, Martin Shkreli was drinking beer at Tuttles, a bar in the Murray Hill neighborhood of Manhattan that has sticky wooden tables and sports playing on TV. He was taking a break from.. The New Yorker
On Wednesday , a Brooklyn federal judge ruled that Martin Shkreli will be tried for securities fraud separately from a lawyer who is being charged alongside him. Both Shkreli and lawyer Evan Greebel,.. Source: Wochit Headline News -
The infamous ‘Pharma-Bro’ is tussling with his own corporate attorney in a trial that could send one of them to prison for 20 years. The finger pointing between Martin Shkreli and his former lawyer.. Source: Wochit News -
Mallinckrodt Pharmaceuticals is no longer a member of the powerful pharmaceutical lobby, the Pharmaceutical Research and Manufacturers of America, or PhRMA, the group said.
The Wall Street Journal.. Business Insider
You would think that if a United States Senator has it on good authority that Medicare was spending hundreds of millions on a drug that may not work, there would be an uproar.
Especially if the drug.. Business Insider
Authorerd by Mike Krieger via Liberty Blitzkrieg
When I first started becoming aware of how sleazy, parasitic and corrupt the U.S. economy was, I only had expertise in one industry, financial.. Zero Hedge
This article appears in the Spring 2017 issue of The American Prospect magazine. Subscribe here.
Rob Frankil of Sellersville, Pennsylvania, followed his father into the family business after.. The American Prospect
(And want to get The Morning Email each weekday? Sign up here.)
*INSIDE THE LONDON TERROR ATTACK *London police have arrested several people in overnight raids in connection with the.. Huffington Post
· *The effectiveness of Mallinckrodt Pharmaceuticals' blockbuster drug H.P. Acthar over cheaper alternatives is being questioned by an Oregon State University study.*
· *The drug is prescribed by a.. Business Insider
Former pharmaceutical executive Martin Shkreli is trolling journalists who have written about him by purchasing the internet domains associated with their names.
A recent look at the domains.. Business Insider
Retrophin, a San Diego-based biotech that Martin Shkreli co-founded and led before his ouster in 2014, plans to close its research and development office in Cambridge, Massachusetts by the end of the.. bizjournals
Here's the good news: Valeant Pharmaceuticals has raised $1.1 billion dollars in asset sales it will use to pay down debt. It's also taking this opportunity to refinance more of its $30 billion.. Business Insider
For a few hours Monday, Martin Shkreli, a pharmaceutical executive most famous for raising the price of the drug Daraprim by 5,000 percent, was made an administrator on a popular UC Berkeley Facebook.. SFGate
*Welcome to Finance Insider, Business Insider's summary of the top stories of the past 24 hours.*
Kraft Heinz, the consumer giant backed by Brazilian billionaire Jorge Lehmann and Warren Buffett,.. Business Insider
Controversial pharmaceutical executive Martin Shkreli used a speaking appearance at UMass Boston on Thursday to defend the high cost of some rare disease treatments, including a drug developed by.. bizjournals